These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 32410620)

  • 1. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer.
    Liu Y; Wu J; Huang W; Weng S; Wang B; Chen Y; Wang H
    J Transl Med; 2020 May; 18(1):201. PubMed ID: 32410620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer.
    Wang H; Wu X; Chen Y
    Front Oncol; 2019; 9():1212. PubMed ID: 31781506
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer.
    Tang K; Cheng Y; Li Q
    Med Sci Monit; 2021 Oct; 27():e934359. PubMed ID: 34716287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma.
    Zhang W; Lyu P; Andreev D; Jia Y; Zhang F; Bozec A
    Front Cell Dev Biol; 2022; 10():974851. PubMed ID: 36578780
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Lu X; Liu X
    J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signature of six-hypoxia-related genes to evaluate the tumor immune microenvironment and predict prognosis in gastric cancer.
    Zhou K; Cai C; Ding G; He Y; Hu D
    BMC Med Genomics; 2022 Dec; 15(1):261. PubMed ID: 36527012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
    Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
    Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
    Fei H; Han X; Wang Y; Li S
    J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients.
    Jiang F; Ma Q
    Genet Res (Camb); 2023; 2023():4674536. PubMed ID: 36923953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis.
    Li X; Cai H; Cai Y; Zhang Q; Ding Y; Zhuang Q
    Front Immunol; 2021; 12():629854. PubMed ID: 34194423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer.
    Chen S; Liu W; Huang Y
    Sci Rep; 2021 Mar; 11(1):7141. PubMed ID: 33785812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
    Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
    Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and immune-related gene signatures: Predictive stratification and prognostic implications in gastric cancer.
    Shao J; Zhang W; Li Y; Tang Y; Fan L
    J Gene Med; 2024 Jan; 26(1):e3635. PubMed ID: 37984993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
    Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
    Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.